Phase I/II Sorafenib With Radiation and Temozolomide in Newly Diagnosed Glioblastoma or Gliosarcoma

This study is ongoing, but not recruiting participants.

Study NCT00734526 Information provided by M.D. Anderson Cancer Center

First Received: August 12, 2008 Last Updated: February 13, 2012 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	August 2013 (Final data collection date for primary outcome measure)